MedPath

Effects of 8-week walking break strategy on vascular function in young adult office workers

Phase 1
Completed
Conditions
The study will perform on healthy human volunteers.
prolonged sitting, vascular function
Registration Number
TCTR20220223001
Lead Sponsor
/A
Brief Summary

The results showed that the baseline characteristics of the participants were not different between the control and intervention groups. The metabolic risk factors were not changed across 8 weeks of intervention in both control and intervention groups. The popliteal FMD was significantly increased in walking break participants. Furthermore, the effect of walking breaks on the FMD was greater than the attention control groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
26
Inclusion Criteria

The participants will be recruited if they are healthy sedentary men and women who are desk-based office workers aged between 18-35 years will be recruited. All participants work at least 35 hours per week and report sitting for a minimum of 75% of their normal workday. All participants engage in less than 60 minutes of moderate to vigorous-intensity physical activity per week. Because fluctuations in estrogen can affect cardiovascular measurements, women will be reported for outcome measurements in the early follicular phase. Women reporting contraceptive use will be tested during the placebo week.

Exclusion Criteria

Exclusion criteria include the following: any history or symptom of CVDs, pulmonary, metabolic, or neurological disease, BMI over 30 kg/m2, pregnant women, taking medication that may influence vascular function, and smoking

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Vacular parameters The vascular parameters will be measure at pre-test and 8-week of intervention. Brachial-Ankle Pulse wave velocity, Flow-mediated dilation
Secondary Outcome Measures
NameTimeMethod
Blood chemistry The blood chemistry will be measure at pre-test and 8-week of intervention. fasting blood sugar, total choresterol, triglycerides
© Copyright 2025. All Rights Reserved by MedPath